For IL-2, significant higher levels were induced in mice selleck chemicals immunized with rPrn, rFim2 or rFim3 when compared to the control mice (P < 0.05 for all three proteins). For TNF-α, significant higher level was only observed in mice immunized with rPrn Z VAD FMK (P = 0.037), but not in those with rFim2 or rFim3. The IL-4 induction was not found in all groups of mice (Figure 3). Figure 3 Cytokine responses in immunized and control mice. Two weeks after the second immunization, blood samples were collected from five mice from each group. The cytokines were
determined by ELISA and are expressed as pg/mL sera. Results are the mean responses for five mice per group. An asterisk symbol (*) indicates a statistically significant difference (P < 0.05) between immunized and control group. Intranasal challenge
with B. pertussis Seven days after the intranasal challenge with B. pertussis, the bacterial loads were significantly lower in the lungs of mice immunized with high or low doses of rPrn, compared APR-246 mw to those observed in the control mice (P = 0.021 and P = 0.039). For the mice immunized with rFim2 or rFim3, no significant difference was observed in the bacterial loads in the lungs compared to the control mice (Figure 4). Figure 4 Protection against intranasal challenge with B. pertussis. Two weeks after the second immunization, the mice were challenged intranasally with B. pertussis 18323, and CFU counts were performed on individual lung homogenate. Results are mean viable B. pertussis counts from five mice per group. An asterisk symbol (*) indicates a statistically significant difference (P < 0.05) between immunized and control group. Intracerebral challenge with B. pertussis Two weeks after the intracerebral challenge with a lethal dose of B. pertussis, none of
the mice in the control group survived (Figure 5). In contrast, a dose-dependent protection was observed in mice immunized with different doses of the reference vaccine. For the mice immunized with rPrn, some protection against the lethal dose of intercerebral challenge was noticed when compared to the control mice (P = 0.005). The level of this protection provided from immunization with rPrn was clearly higher than that from the immunization oxyclozanide with 0.02 IU of reference vaccine (P = 0.027). The result suggested that immunization with rPrn alone can confer partial protection against a lethal intracerebral B. pertussis challenge. Such intracerebral challenge assays were also performed in the groups immunized with different doses of rFim2 and rFim3. However, no significant protection was observed as none of mice were survived in the groups immunized with 20 μg dose of rFim2 and 4 μg dose of rFim3 and a few (less than three) survival mice in other dose groups. Figure 5 Protection against intracerebral challenge with B. pertussis.
Related posts:
- The nanoparticle containing TpD induced robust anti-nicotine anti
- There were no significant differences in GMC 2 weeks following th
- 016) When ELF levels were lower than plasma levels there was a s
- The correlation between the antibody concentration in sera and in
- WT B6, CD1d−/−, and Jα18−/− mice were immunized with an uveitogen